Recipient Characteristics
|
|
|
|
|
|
Female, % |
39.3 |
47.2 |
37.2 |
42.5 |
39.2 |
Black, % |
31.6 |
15.0 |
12.7 |
13.3 |
33.6 |
Hispanic, % |
10.5 |
11.4 |
15.2 |
14.5 |
17.9 |
Median (IQR) Age, years |
53.0 (41.0-60.0) |
52.0 (40.0-61.0) |
50.0 (36.0-60.0) |
50.0 (39.0-60.0) |
55.0 (43.0-63.0) |
Preemptive Transplant, % |
16.0 |
28.1 |
35.9 |
29.9 |
10.6 |
Median (IQR) Years on Dialysis |
3.0 (1.1-4.8) |
1.0 (0.0-2.4) |
0.5 (0.0-1.6) |
0.9 (0.0-2.3) |
3.6 (1.5-5.9) |
Median (IQR) BMI, kg/m2
|
26.5 (23.5-31.0) |
26.8 (23.3-30.9) |
27.2 (23.6-31.4) |
27.5 (23.8-31.7) |
28.0 (24.3-32.1) |
College Educated, % |
59.6 |
68.6 |
61.5 |
64.7 |
48.1 |
Public Insurance, % |
70.9 |
46.4 |
42.4 |
45.5 |
77.5 |
Diabetes, % |
27.0 |
18.5 |
21 |
21.3 |
28.8 |
Hypertension, % |
21.5 |
14.5 |
15.7 |
15.3 |
24.2 |
Hepatitis C, % |
2.0 |
1.5 |
2.1 |
2.0 |
5.5 |
Previous Transplant, % |
11.3 |
23.7 |
11.2 |
16.4 |
14.0 |
PRA>80 at Transplant, % |
6.4 |
20.9 |
3.8 |
9.7 |
16.4 |
Median (IQR) eGFR Pre-transplant, mL/min per 1.73 m2
|
7.4 (5.2-10.6) |
8.0 (5.6-11.7) |
8.9 (6.2-12.9) |
8.3 (5.7-12.0) |
6.7 (4.9-9.5) |
Antibody Depleting Induction, % |
64.5 |
69.0 |
63.5 |
74.0 |
73.5 |
Delayed Graft Function, % |
7.6 |
4.2 |
3.1 |
3.7 |
27.8 |
Donor Characteristics
|
|
|
|
|
|
Female, % |
64.8 |
63.3 |
62.7 |
63.9 |
39.1 |
Black, % |
7.1 |
8.5 |
10.5 |
8.4 |
13.6 |
Hispanic, % |
9.3 |
9.7 |
14.7 |
13.1 |
14.5 |
Median (IQR) Age, years |
52.0 (41.0-58.0) |
44.0 (34.0-53.0) |
42.0 (33.0-52.0) |
44.0 (34.0-52.0) |
41.0 (29.0-52.0) |
Median (IQR) BMI, kg/m2
|
26.1 (23.4-28.8) |
26.1 (23.3-29.0) |
26.7 (23.9-29.8) |
26.6 (23.8-29.7) |
27.2 (23.7-31.7) |
Median (IQR) eGFR, mL/min per 1.73 m2
|
93.1 (81.7-103.0) |
97.6 (86.0-109.0) |
98.9 (85.9-110.8) |
97.1 (84.4-109.0) |
88.6 (58.9-112.6) |
Median (IQR) LKDPI or KDPI, % |
19.8 (5.5-35.6) |
12.4 (−1.2-26.6) |
12.7 (−1.2-27.5) |
13.6 (0.2-28.0) |
46.8 (25.5-68.6) |
Blood Type O, % |
2.3 |
46.7 |
64.9 |
55.2 |
47.4 |
1 Renal Vein, % |
88.5 |
88.2 |
|
|
|
2 Renal Veins, % |
5.1 |
3.7 |
|
|
|
3 Renal Veins, % |
0.4 |
0.2 |
|
|
|
Missing Vein Information, % |
6 |
7.9 |
|
|
|
1 Renal Artery, % |
70.1 |
72.4 |
|
|
|
2 Renal Arteries, % |
21.2 |
18.6 |
|
|
|
3 Renal Arteries, % |
3.1 |
1.4 |
|
|
|
Missing Artery Information, % |
6 |
7.9 |
|
|
|
Transplant Characteristics
|
|
|
|
|
|
Zero HLA mismatch, % |
0.4 |
0.9 |
6.9 |
0.7 |
6.7 |
1 HLA mismatch, % |
0.9 |
2.0 |
4.6 |
0.9 |
1.2 |
2 HLA mismatch, % |
4.7 |
6.4 |
14.9 |
4.9 |
4.7 |
3 HLA mismatch, % |
12.4 |
16.8 |
25.3 |
13.6 |
13.8 |
4 HLA mismatch, % |
26.3 |
26.2 |
16.4 |
26.8 |
27.2 |
5 HLA mismatch, % |
36.7 |
31.1 |
20.0 |
32.7 |
31.5 |
6 HLA mismatch, % |
17.2 |
14.7 |
11.0 |
18.5 |
14.8 |
Median (IQR) cold ischemia time, hours |
6.4 (1.4-9.8) |
9.3 (6.3-12.5) |
1.0 (0.7-1.9) |
1.4 (0.9-3.1) |
16.5 (11.3-22.3) |